Delivery Order SPE2DE24D0013-SPE2D625F8X5E

Award Date 5/22/25
Potential Completion Date 5/30/25
Potential Value $5.8K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide the U.S. Department of Defense with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $6,800.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid has been awarded several...
This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, provides the company with a firm fixed-price delivery order valued at $13,600.00 from the Department of Defense's Defense Logistics Agency. The contract is to deliver GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is part of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The award, with a ceiling value of $21,828.00, is for the delivery of medical testing equipment, reagents, and consumables for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract is a firm fixed-price delivery order with no set-aside designation. Cepheid has several significant federal...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency, an agency within the Department of Defense. The contract is a delivery order with a firm fixed-price pricing type and a ceiling value of $2,244.00. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The contract has a ceiling value of...
This federal contract award is a delivery order from the Medical Supply Chain division of the U.S. Department of Defense to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $6,800.00, is a firm fixed-price agreement to provide diagnostic equipment and services related to the detection of COVID-19, influenza, and respiratory syncytial virus (RSV). The contract does not have a set-aside designation. Cepheid is an...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for $21,080.00. The contract is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the government with XPCOV2/FLU/RSV-10 diagnostic testing systems, reagents, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus. This award is part of a larger...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), which is the Department of Defense's (DoD) combat logistics support agency. The contract, worth $1,750.00, is a delivery order issued under Cepheid's existing Indefinite Delivery Contract (IDC) with the agency. The contract is for firm fixed-price procurement of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the U.S. Department of Defense's Medical Supply Chain program. The $6,800.00 firm fixed-price delivery order is for the provision of XPCOV2/FLU/RSV-10 diagnostic products and services, with a performance period ending on May 30, 2025. The contract is not designated as a set-aside. Cepheid holds several significant Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans...
This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, involves the delivery of diagnostic systems, reagents, and test kits for the detection of infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The $2,910.40 firm fixed-price delivery order was awarded by the Defense Logistics Agency, a component of the U.S. Department of Defense, and has an ultimate completion date of March 14, 2025. The contract does not...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F8X5E
    Delivery Order

This contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is a Firm Fixed Price Delivery Order valued at $5,760.00. It is not designated as a set-aside contract. The award was made by the Medical Supply Chain division of the U.S. Department of Defense. The contract will provide molecular diagnostic equipment, reagents, and associated services to support infectious disease detection, including for COVID-19, influenza, respiratory syncytial virus (RSV), methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. This award is part of Cepheid's larger portfolio of federal Indefinite Delivery Vehicle (IDV) contracts, including a $5,000,000 single-award contract with the Indian Health Service and a $9,248,933.20 contract with the Department of Veterans Affairs' Veterans Integrated Service Network 8 for molecular analyzer leases and cost-per-test services.

Generated 8/24/25, 12:45 AM